vs

Side-by-side financial comparison of Organon & Co. (OGN) and V F CORP (VFC). Click either name above to swap in a different company.

V F CORP is the larger business by last-quarter revenue ($2.9B vs $1.5B, roughly 1.9× Organon & Co.). V F CORP runs the higher net margin — 10.5% vs -13.6%, a 24.1% gap on every dollar of revenue. On growth, V F CORP posted the faster year-over-year revenue change (1.5% vs -5.3%). V F CORP produced more free cash flow last quarter ($977.9M vs $96.0M). Over the past eight quarters, V F CORP's revenue compounded faster (10.1% CAGR vs -3.6%).

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

The F. W. Woolworth Company was a retail company and one of the pioneers of the five-and-dime store. It was among the most successful American and international five-and-dime businesses, setting trends and creating the modern retail model that stores worldwide follow today.

OGN vs VFC — Head-to-Head

Bigger by revenue
VFC
VFC
1.9× larger
VFC
$2.9B
$1.5B
OGN
Growing faster (revenue YoY)
VFC
VFC
+6.8% gap
VFC
1.5%
-5.3%
OGN
Higher net margin
VFC
VFC
24.1% more per $
VFC
10.5%
-13.6%
OGN
More free cash flow
VFC
VFC
$881.9M more FCF
VFC
$977.9M
$96.0M
OGN
Faster 2-yr revenue CAGR
VFC
VFC
Annualised
VFC
10.1%
-3.6%
OGN

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
OGN
OGN
VFC
VFC
Revenue
$1.5B
$2.9B
Net Profit
$-205.0M
$300.8M
Gross Margin
49.2%
56.6%
Operating Margin
-9.8%
10.1%
Net Margin
-13.6%
10.5%
Revenue YoY
-5.3%
1.5%
Net Profit YoY
-288.1%
79.3%
EPS (diluted)
$-0.78
$0.76

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OGN
OGN
VFC
VFC
Q4 25
$1.5B
$2.9B
Q3 25
$1.6B
$2.8B
Q2 25
$1.6B
$1.8B
Q1 25
$1.5B
$2.0B
Q4 24
$1.6B
$2.8B
Q3 24
$1.6B
$2.8B
Q2 24
$1.6B
$1.9B
Q1 24
$1.6B
$2.4B
Net Profit
OGN
OGN
VFC
VFC
Q4 25
$-205.0M
$300.8M
Q3 25
$160.0M
$189.8M
Q2 25
$145.0M
$-116.4M
Q1 25
$87.0M
$-150.8M
Q4 24
$109.0M
$167.8M
Q3 24
$359.0M
$52.2M
Q2 24
$195.0M
$-258.9M
Q1 24
$201.0M
$-418.3M
Gross Margin
OGN
OGN
VFC
VFC
Q4 25
49.2%
56.6%
Q3 25
53.5%
52.2%
Q2 25
54.8%
53.9%
Q1 25
55.6%
52.7%
Q4 24
56.3%
56.3%
Q3 24
58.3%
52.2%
Q2 24
58.4%
52.0%
Q1 24
59.0%
48.4%
Operating Margin
OGN
OGN
VFC
VFC
Q4 25
-9.8%
10.1%
Q3 25
15.2%
11.2%
Q2 25
14.4%
-4.9%
Q1 25
6.7%
2.2%
Q4 24
8.1%
8.0%
Q3 24
13.1%
9.9%
Q2 24
14.6%
-12.6%
Q1 24
14.5%
-15.0%
Net Margin
OGN
OGN
VFC
VFC
Q4 25
-13.6%
10.5%
Q3 25
10.0%
6.8%
Q2 25
9.1%
-6.6%
Q1 25
5.8%
-7.5%
Q4 24
6.8%
5.9%
Q3 24
22.7%
1.9%
Q2 24
12.1%
-13.6%
Q1 24
12.4%
-17.6%
EPS (diluted)
OGN
OGN
VFC
VFC
Q4 25
$-0.78
$0.76
Q3 25
$0.61
$0.48
Q2 25
$0.56
$-0.30
Q1 25
$0.33
$-0.37
Q4 24
$0.42
$0.43
Q3 24
$1.38
$0.13
Q2 24
$0.75
$-0.67
Q1 24
$0.78
$-1.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OGN
OGN
VFC
VFC
Cash + ST InvestmentsLiquidity on hand
$574.0M
$1.5B
Total DebtLower is stronger
$8.6B
$3.6B
Stockholders' EquityBook value
$752.0M
$1.8B
Total Assets
$12.9B
$10.4B
Debt / EquityLower = less leverage
11.49×
1.99×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OGN
OGN
VFC
VFC
Q4 25
$574.0M
$1.5B
Q3 25
$672.0M
$419.1M
Q2 25
$599.0M
$642.4M
Q1 25
$547.0M
$429.4M
Q4 24
$675.0M
$1.4B
Q3 24
$763.0M
$492.2M
Q2 24
$704.0M
$637.4M
Q1 24
$575.0M
$674.6M
Total Debt
OGN
OGN
VFC
VFC
Q4 25
$8.6B
$3.6B
Q3 25
$8.8B
$3.5B
Q2 25
$8.9B
$3.6B
Q1 25
$9.0B
$3.4B
Q4 24
$8.9B
$3.9B
Q3 24
$8.7B
$4.0B
Q2 24
$8.7B
$3.9B
Q1 24
$8.7B
$4.7B
Stockholders' Equity
OGN
OGN
VFC
VFC
Q4 25
$752.0M
$1.8B
Q3 25
$906.0M
$1.5B
Q2 25
$733.0M
$1.3B
Q1 25
$542.0M
$1.5B
Q4 24
$472.0M
$1.7B
Q3 24
$493.0M
$1.4B
Q2 24
$144.0M
$1.4B
Q1 24
$48.0M
$1.7B
Total Assets
OGN
OGN
VFC
VFC
Q4 25
$12.9B
$10.4B
Q3 25
$13.6B
$10.6B
Q2 25
$13.5B
$10.2B
Q1 25
$13.2B
$9.4B
Q4 24
$13.1B
$10.6B
Q3 24
$12.8B
$12.2B
Q2 24
$12.2B
$11.5B
Q1 24
$11.9B
$11.6B
Debt / Equity
OGN
OGN
VFC
VFC
Q4 25
11.49×
1.99×
Q3 25
9.74×
2.40×
Q2 25
12.14×
2.76×
Q1 25
16.52×
2.30×
Q4 24
18.81×
2.31×
Q3 24
17.75×
2.86×
Q2 24
60.11×
2.84×
Q1 24
181.54×
2.84×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OGN
OGN
VFC
VFC
Operating Cash FlowLast quarter
$141.0M
$1.0B
Free Cash FlowOCF − Capex
$96.0M
$977.9M
FCF MarginFCF / Revenue
6.4%
34.0%
Capex IntensityCapex / Revenue
3.0%
1.1%
Cash ConversionOCF / Net Profit
3.36×
TTM Free Cash FlowTrailing 4 quarters
$538.0M
$357.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OGN
OGN
VFC
VFC
Q4 25
$141.0M
$1.0B
Q3 25
$264.0M
$-227.0M
Q2 25
$220.0M
$-145.5M
Q1 25
$75.0M
$-171.1M
Q4 24
$390.0M
$918.1M
Q3 24
$141.0M
$-301.6M
Q2 24
$332.0M
$19.8M
Q1 24
$76.0M
Free Cash Flow
OGN
OGN
VFC
VFC
Q4 25
$96.0M
$977.9M
Q3 25
$218.0M
$-253.5M
Q2 25
$181.0M
$-173.7M
Q1 25
$43.0M
$-193.0M
Q4 24
$335.0M
$899.7M
Q3 24
$99.0M
$-322.4M
Q2 24
$300.0M
$-5.4M
Q1 24
$30.0M
FCF Margin
OGN
OGN
VFC
VFC
Q4 25
6.4%
34.0%
Q3 25
13.6%
-9.0%
Q2 25
11.4%
-9.9%
Q1 25
2.8%
-9.6%
Q4 24
21.0%
31.7%
Q3 24
6.3%
-11.7%
Q2 24
18.7%
-0.3%
Q1 24
1.8%
Capex Intensity
OGN
OGN
VFC
VFC
Q4 25
3.0%
1.1%
Q3 25
2.9%
0.9%
Q2 25
2.4%
1.6%
Q1 25
2.1%
1.1%
Q4 24
3.5%
0.6%
Q3 24
2.7%
0.8%
Q2 24
2.0%
1.3%
Q1 24
2.8%
Cash Conversion
OGN
OGN
VFC
VFC
Q4 25
3.36×
Q3 25
1.65×
-1.20×
Q2 25
1.52×
Q1 25
0.86×
Q4 24
3.58×
5.47×
Q3 24
0.39×
-5.78×
Q2 24
1.70×
Q1 24
0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OGN
OGN

Segment breakdown not available.

VFC
VFC

Outdoor$1.9B67%
Sales Channel Through Intermediary$813.4M28%
Other$136.3M5%

Related Comparisons